Thousands more patients with multiple sclerosis in England will soon be able to access Merck KGaA's take-at-home tablet Mavenclad, reducing their need for clinic visits. New guidance (PDF) from health ...
Thinking about leveling up your software development game in 2025? It’s a smart move. The tech world moves fast, and getting ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback